Search | HMA-EMA Catalogues of real-world data sources and studies

Results(4739)

NordicRWE

Norway

First published:

02/09/2026

Last updated 02/09/2026

Institution Other ENCePP partner

Observational Study on the Safety and Effectiveness of Tepezza (teprotumumab) in South Korea

Korea, Republic of

EU PAS number:

EUPAS1000001085

First published:

02/09/2026

Last updated 02/09/2026

Study Planned

Effects of triple pharmacological therapy on post-discharge outcomes in patients with COPD

Belgium

France

Korea, Republic of

Malta

Poland

Singapore

Spain

EU PAS number:

EUPAS1000000444

First published:

25/09/2025

Last updated 02/09/2026

Study Planned

Xarelto Paediatric VTE PASS Drug Utilization Study: An observational, longitudinal, multi-source drug utilization safety study to evaluate the drug use patterns and safety of rivaroxaban oral suspension in children under two years with venous thromboembolism (XAPAEDUS)

Denmark

France

Spain

Sweden

EU PAS number:

EUPAS46800

First published:

10/05/2023

Last updated 01/09/2026

Study Planned

A Prospective, Observational Cohort Study to Assess Long-Term Safety in Patients Prescribed Epidyolex® with a Focus on Drug-induced Liver Injury (DILI)

Germany

Italy

Spain

United Kingdom

EU PAS number:

EUPAS47466

First published:

29/06/2022

Last updated 01/09/2026

Study Ongoing

Detection of therapeutic cascades associated with gabapentinoids and benzodiazepines in adults over 65 years old in Spain using BIFAP through prescription sequence symmetry analysis (GABALOOP)

Spain

EU PAS number:

EUPAS1000000241

First published:

19/07/2024

Last updated 01/09/2026

Study Ongoing

Implementation of controlled access to and distribution of medicinal products in European Union (CONTROL-EU)

Austria

Greece

Latvia

Netherlands

Portugal

Slovenia

Spain

Sweden

EU PAS number:

EUPAS1000000313

First published:

18/09/2024

Last updated 01/09/2026

Study Finalised

Real World Evaluation of Sotorasib among Chinese Non-Small Cell Lung Cancer Patients (20240175)

China

EU PAS number:

EUPAS1000000636

First published:

01/07/2025

Last updated 31/08/2026

Study Finalised

209452 - A targeted safety study, EPI-ZOSTER-030 VS US DB, to evaluate the safety of Shingrix in adults ≥ 50 years of age in the United States

United States

EU PAS number:

EUPAS37156

First published:

11/09/2020

Last updated 31/08/2026

Study Finalised

Evaluation of the Effectiveness of the Additional Risk Minimisation Measures for Hemgenix®: PASS Survey Among Physicians in European Countries

Austria

France

Germany

Ireland

Italy

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000001088

First published:

31/08/2026

Last updated 31/08/2026

Study Planned

Gesundheitsforen Leipzig GmbH

Germany

First published:

28/08/2026

Last updated 28/08/2026

Institution Other ENCePP partner

Health Impact - Swedish Population Evidence Enabling Data-linkage

Sweden

First published:

26/05/2025

Last updated 28/08/2026

Data source

Human

Birth registry Cancer registry Death registry Disease registry Drug registry Hospital discharge records Hospital inpatient records Hospital outpatient visit records Population registry Primary care medical records Vaccination registry

Record completeness: 90%

Compare Compare

European Sickle Cell Disease Cohort – Hydroxyurea – Extension study (ESCORT-HU Extension)

France

Germany

Greece

Italy

EU PAS number:

EUPAS1000000066

First published:

18/07/2024

Last updated 28/08/2026

Study Finalised

Orphacol® patient surveillance database (Orphabase)

France

Germany

Italy

Spain

Switzerland

United Kingdom

EU PAS number:

EUPAS37229

First published:

16/09/2020

Last updated 28/08/2026

Study Ongoing

Frequency of HIV diagnoses among people using oral and LA PrEP (223555)

United States

EU PAS number:

EUPAS1000000371

First published:

21/11/2024

Last updated 28/08/2026

Study Finalised

NONINTERVENTIONAL CLINICAL STUDY TO CONFIRM ORIGINAL SOURCES AND VERIFY SOURCE DATA FOR UNTREATED PATIENT DATA COMPILED FROM TK2D PUBLICATIONS

United Kingdom

EU PAS number:

EUPAS1000000885

First published:

19/12/2025

Last updated 28/08/2026

Study Finalised

Real-World Evidence Team, University of Eastern Finland (RWE team)

Finland

First published:

20/12/2017

Last updated 27/08/2026

Institution Educational Institution ENCePP partner

Retrospective analysis of adolescent patients suffering from hereditary angioedema treated with berotralstat in Europe: patients’ and treatment characteristics

Belgium

France

Germany

Italy

Portugal

Spain

United Kingdom

EU PAS number:

EUPAS1000000997

First published:

08/05/2026

Last updated 27/08/2026

Study Planned

DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe – supporting international preparedness

Denmark

Finland

Germany

Netherlands

Norway

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS1000000969

First published:

04/05/2026

Last updated 27/08/2026

Study Finalised

DARWIN EU® - Prescription of Common Drugs Before and During Pregnancy in Europe

Norway

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS1000001101

First published:

27/08/2026

Last updated 27/08/2026

Study Planned

DARWIN EU® - Pregnancies amongst statin users with familial hypercholesterolaemia

Finland

Spain

United Kingdom

United States

EU PAS number:

EUPAS1000001100

First published:

27/08/2026

Last updated 27/08/2026

Study Planned

DARWIN EU® - Endometriosis and adenomyosis: Incidence, prevalence, diagnosis delay, and treatments in European countries

Hungary

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000001099

First published:

27/08/2026

Last updated 27/08/2026

Study Planned

DARWIN EU® - Characterising the use of JAK inhibitors in Europe: a Drug Utilisation Study Update

Croatia

Denmark

Finland

Germany

Spain

Sweden

EU PAS number:

EUPAS1000000998

First published:

08/05/2026

Last updated 27/08/2026

Study Finalised

Clinical Investigation and research for the Rendu Osler Cohort

Denmark

France

Germany

Italy

First published:

09/04/2025

Last updated 26/08/2026

Data source

Human

Disease registry Drug registry

Record completeness: 83%

Compare Compare

Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review and tool

Italy

Netherlands

United Kingdom (Northern Ireland)

EU PAS number:

EUPAS39757

First published:

04/03/2021

Last updated 26/08/2026

Study Ongoing

An active surveillance, post-authorization safety study of serious infection, malignancy, cardiovascular and other safety events of interest among patients treated with tofacitinib for moderately to severely active rheumatoid arthritis within the Spanish registry of adverse events of biological therapies and biosimilars in rheumatoid diseases (BIOBADASER) (Safety of tofacitinib in BIOBADASER)

Spain

EU PAS number:

EUPAS31129

First published:

05/09/2019

Last updated 26/08/2026

Study Ongoing

An active surveillance, post-authorization safety study (PASS) of serious infection, malignancy, cardiovascular and other safety events of interest among patients treated with tofacitinib for moderately to severely active rheumatoid arthritis within the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis (BSRBR-RA) (Safety of tofacitinib in BSRBR-RA)

United Kingdom

EU PAS number:

EUPAS31126

First published:

05/09/2019

Last updated 26/08/2026

Study Ongoing

DARWIN EU® - Cancer incidence during pregnancy

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000001059

First published:

14/07/2026

Last updated 26/08/2026

Study Ongoing

Post-Authorization Safety Study to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy in North America

Canada

United States

EU PAS number:

EUPAS43819

First published:

15/12/2021

Last updated 26/08/2026

Study Finalised

A post-authorisation safety study (PASS) to describe real-world safety and effectiveness of NUCALA (mepolizumab) in paediatric eosinophilic granulomatosis with polyangiitis (EGPA) patients in Europe (218065)

France

Germany

Italy

Spain

United Kingdom

EU PAS number:

EUPAS49460

First published:

03/11/2022

Last updated 26/08/2026

Study Ongoing

DARWIN EU® - Acute myeloid leukaemia: incidence, patient characteristics, treatments, and survival in the period 2015–2024

Croatia

Denmark

Finland

Germany

Netherlands

Norway

Spain

EU PAS number:

EUPAS1000000773

First published:

08/10/2025

Last updated 25/08/2026

Study Finalised

DARWIN EU® - Sex differences in prescribing of benzodiazepines and benzodiazepine-related drugs over time in adolescents and young adults.

Denmark

Finland

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000001096

First published:

25/08/2026

Last updated 25/08/2026

Study Planned

DARWIN EU® - Use of antiretroviral therapies in paediatric patients

Germany

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000000545

First published:

09/04/2025

Last updated 25/08/2026

Study Finalised

DARWIN EU® - Sex-specific incidence of selected adverse events for major cardio-metabolic drug classes

Belgium

Finland

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000001081

First published:

11/08/2026

Last updated 25/08/2026

Study Ongoing

Unidade Local de Saúde de Matosinhos

Portugal

First published:

01/02/2024

Last updated 21/08/2026

Data source

Human

Administrative healthcare records (e.g., claims) Emergency care discharge records Hospital discharge records Hospital inpatient records Hospital outpatient visit records Pharmacy dispensing records Primary care medical records Specialist ambulatory care records

Record completeness: 93%

Compare Compare

Vedolizumab-4081: Infection Outcomes among Advanced Therapy-naive Older Adult US Patients With UC/CD Initiating ENTYVIO, TNF-alpha Inhibitors, or Ustekinumab: A Retrospective Observational Matched-Cohort Study Using Medicare Claims Data, 2016-2025

United States

EU PAS number:

EUPAS1000000767

First published:

17/12/2025

Last updated 21/08/2026

Study Planned

Metamizole and Acute Kidney Injury (M-AKI)

Netherlands

EU PAS number:

EUPAS1000000740

First published:

29/09/2025

Last updated 21/08/2026

Study Ongoing

Prospective, Registry-Based Observational Cohort Study of Zavegepant Safety in Pregnancy

United States

EU PAS number:

EUPAS1000000335

First published:

18/10/2024

Last updated 21/08/2026

Study Planned

DARWIN EU® - Encephalitis risk in pediatric varicella vaccine recipients

Denmark

Finland

Norway

Spain

EU PAS number:

EUPAS1000000813

First published:

06/11/2025

Last updated 21/08/2026

Study Finalised

DARWIN EU® - Capturing suicidality and depression related variables in databases

Denmark

Estonia

Finland

France

Germany

Greece

Netherlands

Norway

Portugal

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS1000000825

First published:

10/11/2025

Last updated 21/08/2026

Study Finalised

Search all content

Results(4739)